$182.34-3.40 (-1.83%)
The Hershey Company, together with its subsidiaries, engages in the manufacture and sale of confectionery products and pantry items in the United States and internationally.
The Hershey Company in the Consumer Defensive sector is trading at $182.34. The stock is currently 24% below its 52-week high of $239.48, remaining 4.8% below its 200-day moving average. Technical signals show oversold RSI of 25 and bearish MACD signal, explaining why HSY maintains its current current market pressure. The Whystock Score of 70/100 reflects a high-conviction bullish alignment.
Simplified model based on P/E and ROE. Not a substitute for full valuation analysis. Data may be delayed. See our Terms.
The Hershey Company, together with its subsidiaries, engages in the manufacture and sale of confectionery products and pantry items in the United States and internationally. It operates through three segments: North America Confectionery, North Ameri...
The Hershey Company opened fiscal 2026 with what management described as a strong first quarter, driven by pricing, brand momentum across core confection, and continued growth in salty snacks and newer platforms. Hershey (NYSE:HSY) reported first-quarter net sales growth of 10.6%, while reaffirming
The Hershey Co (HSY) reports robust growth in core brands and premium chocolate, while navigating market share challenges and macroeconomic pressures.
Roblox downgraded, Hershey upgraded: Wall Street's top analyst calls
Pre-Market Stock Futures: Futures are trading mixed as we get ready to finish off another wild week. What a difference a day makes: after a flat-to-down Wednesday, all the major indices exploded higher on Thursday and closed solidly in the green. Big earnings for members of the Magnificent 7, oil prices falling somewhat, and while ... Here Are Friday’s Top Wall Street Analyst Research Calls: Avis Budget, Caterpillar, Celestica, Commvault Systems, Ciena, Dutch Bros. e.l.f. Beauty, Hershey, Roblox
Hershey says it's benefiting from the growing use of GLP-1 weight-loss drugs even as people cut down on snacks. Here's why.